• Contract win with Intermountain Health, a major U.S. health system
• Contract for deployment of 4DMedical's FDA-cleared Pulmonary Hypertension Analysis (PHA™) product
• Sale won via 4DMedical's strategic distribution partnership with Nuance Communications

4DMedical Limited, a global leader in respiratory imaging technology, has secured a commercial contract with Intermountain Health, a major U.S. health system headquartered in Utah, for the implementation of 4DMedical's recently FDA-cleared Pulmonary Hypertension Analysis (PHA™) product. Intermountain Health is a U.S. health system consisting of 33 hospitals, 400 clinics, and includes nearly 4,000 physicians. Serving communities across Utah, Idaho, Nevada, Colorado, and Montana, Intermountain Health is widely regarded as a leader in value-based care, innovation, and the early adoption of advanced technologies that improve patient outcomes. The contract was secured through Nuance Communications, a Microsoft-owned company, as part of 4DMedical's strategic distribution partnership. Nuance provides AI-driven clinical documentation and diagnostic imaging solutions to healthcare providers across the United States. This agreement represents the first major deployment of 4DMedical's PHA™ algorithm within a large, integrated health network, and highlights the commercial advantages enabled by 4DMedical's distribution agreement with Nuance's nationwide network. The PHA™ algorithm integrates seamlessly into existing radiology workflows via Nuance's PowerScribe platform, enabling enhanced clinical decision-making.

Under the terms of the Innovation Site agreement, the first year's payment by Intermountain Health to Nuance is fixed, at a price that represents only a small volume of scans. However, in future years, the payments will build to the number of scans in use across the 33 hospitals in the system, thereby representing a significant opportunity.

This contract establishes 4DMedical within a health system of 33 hospitals and nearly 4,000 physicians. As the contract transitions to full commercial terms, this revenue stream will become meaningful for the company. Furthermore, under those terms, 4DMedical can grow revenue through increased usage of PHA™ and expansion to other products in the portfolio, further growing the opportunity within this large health system.